While serum from all patients increased the number of DCX+ cells and neuronal (MAP2+) cells between TW0 and TW4, patients who developed IFN-α–induced depression had a significantly lower increase in the number of DCX+ cells between TW0 and TW4 (Supplementary Table 1). Here, MAP2 is linked to depressive symptom measurement.